Fda Seizes Contaminated Heparin From A Cincinnati Manufacturer
March 22, 2017 by Berger Lagnese, LLC
FDA Seizes Contaminated Heparin from a Cincinnati Manufacturer
On November 6, 2008, United States marshalls, acting at the request of the FDA, seized 11 lots of heparin from Celsus Laboratories Inc. in Cincinnati, Ohio. The seized heparin, manufactured with material imported from China, had been found by the FDA to be contaminated with oversulfated chondroitin sulfate, a contaminant that mimics heparin's anticoagulant activity that has been responsible for some 81 deaths this year.